Brief title: CabaGast
Design: Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach
No of patients: 65
Status: Rekrutiierung beendet

Single-arm study to determine response rate in second-line treatment with cabazitaxel after the failure of palliative primary treatment.

Dr. H. Schmalenberg
Universitätsklinikum Jena
Bachstr. 18
07743 Jena

More information